Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,Gene_set
Glutathione metabolism_Homo sapiens_hsa00480,2/52,0.012789203835481992,1.0,0,0,11.655011655011654,50.80598967731846,GSTO2;GPX3,KEGG_2016
Arachidonic acid metabolism_Homo sapiens_hsa00590,2/62,0.0178580782947853,1.0,0,0,9.775171065493646,39.34798932159524,GPX3;PLA2G4B,KEGG_2016
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980,2/73,0.024250549838429176,1.0,0,0,8.302200083021999,30.878505505238966,GSTO2;AKR1C1,KEGG_2016
alpha-Linolenic acid metabolism_Homo sapiens_hsa00592,1/25,0.07935964428957401,1.0,0,0,12.12121212121212,30.712306645500554,PLA2G4B,KEGG_2016
Linoleic acid metabolism_Homo sapiens_hsa00591,1/29,0.09146801691010722,1.0,0,0,10.449320794148381,24.992329255702558,PLA2G4B,KEGG_2016
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141,2/169,0.1073361750531063,1.0,0,0,3.5861574323112784,8.003548670633867,DNAJB12;SEC31B,KEGG_2016
Ether lipid metabolism_Homo sapiens_hsa00565,1/45,0.13835271420668946,1.0,0,0,6.7340067340067336,13.319521579353907,PLA2G4B,KEGG_2016
Nucleotide excision repair_Homo sapiens_hsa03420,1/47,0.14404311872744627,1.0,0,0,6.447453255963894,12.492860016897259,ERCC6,KEGG_2016
Ovarian steroidogenesis_Homo sapiens_hsa04913,1/50,0.15250939797562668,1.0,0,0,6.0606060606060606,11.397145810689672,PLA2G4B,KEGG_2016
Steroid hormone biosynthesis_Homo sapiens_hsa00140,1/58,0.17468503580396127,1.0,0,0,5.224660397074191,9.115834493428812,AKR1C1,KEGG_2016
Long-term depression_Homo sapiens_hsa04730,1/60,0.18013904565852595,1.0,0,0,5.05050505050505,8.656698234430094,PLA2G4B,KEGG_2016
VEGF signaling pathway_Homo sapiens_hsa04370,1/61,0.1828527239724489,1.0,0,0,4.967709885742672,8.440507884706681,PLA2G4B,KEGG_2016
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664,1/68,0.20160235613355587,1.0,0,0,4.45632798573975,7.136622351527637,PLA2G4B,KEGG_2016
PPAR signaling pathway_Homo sapiens_hsa03320,1/69,0.20424605314134425,1.0,0,0,4.391743522178305,6.975976588028628,SORBS1,KEGG_2016
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982,1/69,0.20424605314134425,1.0,0,0,4.391743522178305,6.975976588028628,GSTO2,KEGG_2016
RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622,1/70,0.20688112837392567,1.0,0,0,4.329004329004329,6.820826449046828,OTUD5,KEGG_2016
Thyroid hormone synthesis_Homo sapiens_hsa04918,1/71,0.20950760957797396,1.0,0,0,4.2680324370465215,6.67091428814212,GPX3,KEGG_2016
Adherens junction_Homo sapiens_hsa04520,1/74,0.21733576433090632,1.0,0,0,4.0950040950040965,6.25025315403152,SORBS1,KEGG_2016
RNA degradation_Homo sapiens_hsa03018,1/77,0.22508756085522197,1.0,0,0,3.935458480913027,5.868814612845483,EXOSC1,KEGG_2016
Chemical carcinogenesis_Homo sapiens_hsa05204,1/82,0.2378395256946101,1.0,0,0,3.695491500369549,5.307313726957597,GSTO2,KEGG_2016
GnRH signaling pathway_Homo sapiens_hsa04912,1/91,0.2602743508396837,1.0,0,0,3.3300033300033305,4.482247781408104,PLA2G4B,KEGG_2016
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666,1/93,0.2651708416719468,1.0,0,0,3.258390355164549,4.325125367096316,PLA2G4B,KEGG_2016
Glycerophospholipid metabolism_Homo sapiens_hsa00564,1/95,0.27003540884715144,1.0,0,0,3.1897926634768736,4.176083523776812,PLA2G4B,KEGG_2016
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750,1/98,0.2772728507525331,1.0,0,0,3.092145949288806,3.966460225238543,PLA2G4B,KEGG_2016
Choline metabolism in cancer_Homo sapiens_hsa05231,1/101,0.2844396114654024,1.0,0,0,3.0003000300030003,3.7720801378069018,PLA2G4B,KEGG_2016
Cholinergic synapse_Homo sapiens_hsa04725,1/111,0.3078270184372737,1.0,0,0,2.73000273000273,3.216536397027864,KCNQ5,KEGG_2016
Serotonergic synapse_Homo sapiens_hsa04726,1/112,0.31012393354662904,1.0,0,0,2.7056277056277054,3.16770366818626,PLA2G4B,KEGG_2016
Glutamatergic synapse_Homo sapiens_hsa04724,1/114,0.314695266907252,1.0,0,0,2.658160552897395,3.073233692291243,PLA2G4B,KEGG_2016
Vascular smooth muscle contraction_Homo sapiens_hsa04270,1/120,0.3282310216976141,1.0,0,0,2.525252525252525,2.8132262224271294,PLA2G4B,KEGG_2016
Platelet activation_Homo sapiens_hsa04611,1/122,0.3326841599877838,1.0,0,0,2.483854942871337,2.7336356373266617,PLA2G4B,KEGG_2016
Insulin signaling pathway_Homo sapiens_hsa04910,1/139,0.36938059096977305,1.0,0,0,2.180074122520166,2.1711963257884044,SORBS1,KEGG_2016
Phospholipase D signaling pathway_Homo sapiens_hsa04072,1/144,0.3797902486551503,1.0,0,0,2.104377104377104,2.037323560354595,PLA2G4B,KEGG_2016
Olfactory transduction_Homo sapiens_hsa04740,2/415,0.3991399164682817,1.0,0,0,1.460387002555677,1.3412825932406949,OR4X2;OR4M1,KEGG_2016
Oxytocin signaling pathway_Homo sapiens_hsa04921,1/158,0.4080453899190131,1.0,0,0,1.9179133103183736,1.7191731127047811,PLA2G4B,KEGG_2016
cGMP-PKG signaling pathway_Homo sapiens_hsa04022,1/167,0.4255359247868522,1.0,0,0,1.8145527127563057,1.5503645526245031,ADRA2A,KEGG_2016
Ras signaling pathway_Homo sapiens_hsa04014,1/227,0.5298088815207171,1.0,0,0,1.3349352556401015,0.8480028545887294,PLA2G4B,KEGG_2016
MAPK signaling pathway_Homo sapiens_hsa04010,1/255,0.5718565475131897,1.0,0,0,1.1883541295306002,0.6641320381658149,PLA2G4B,KEGG_2016
Endocytosis_Homo sapiens_hsa04144,1/259,0.5775528041005547,1.0,0,0,1.1700011700011699,0.642278466238702,GBF1,KEGG_2016
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080,1/277,0.6022759260854618,1.0,0,0,1.0939722131057872,0.5546872220806813,ADRA2A,KEGG_2016
Metabolic pathways_Homo sapiens_hsa01100,1/1239,0.9854153581180624,1.0,0,0,0.24457651576295644,0.0035933287658430272,PLA2G4B,KEGG_2016
